Effects of Nitric Oxide on Cell Proliferation Novel Insights

被引:233
作者
Napoli, Claudio [1 ,3 ]
Paolisso, Giuseppe [2 ]
Casamassimi, Amelia [1 ]
Al-Omran, Mohammed [4 ]
Barbieri, Michelangela [2 ]
Sommese, Linda [1 ]
Infante, Teresa [3 ]
Ignarro, Louis J. [5 ]
机构
[1] Univ Naples 2, UOC Immunohematol, Dept Gen Pathol, Excellence Res Ctr Cardiovasc Dis, I-80138 Naples, Italy
[2] Univ Naples 2, Sch Med 1, Div Geriatr, I-80138 Naples, Italy
[3] IRCCS, Fdn SDN, Naples, Italy
[4] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pharmacol, Los Angeles, CA 90095 USA
关键词
cardiovascular diseases; cell cycle; cell proliferation; diagnostic and therapeutic tools; imaging; nitric oxide; type; 2; diabetes; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW-CELLS; CRITICAL LIMB ISCHEMIA; EMBRYONIC STEM-CELLS; METABOLIC INTERVENTION; S-NITROSYLATION; HYPERCHOLESTEROLEMIC MICE; DIABETES-MELLITUS; OXIDATIVE STRESS;
D O I
10.1016/j.jacc.2013.03.070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nitric oxide (NO) has been suggested to be a pathophysiological modulator of cell proliferation, cell cycle arrest, and apoptosis. In this context, NO can exert opposite effects under diverse conditions. Indeed, several studies have indicated that low relative concentrations of NO seem to favor cell proliferation and antiapoptotic responses and higher levels of NO favor pathways inducing cell cycle arrest, mitochondria respiration, senescence, or apoptosis. Here we report the effects of NO on both promotion and inhibition of cell proliferation, in particular in regard to cardiovascular disease, diabetes, and stem cells. Moreover, we focus on molecular mechanisms of action involved in the control of cell cycle progression, which include both cyclic guanosine monophosphate-dependent and -independent pathways. This growing field may lead to broad and novel targeted therapies against cardiovascular diseases, especially concomitant type 2 diabetes, as well as novel bioimaging NO-based diagnostic tools. (C) 2013 by the American College of Cardiology Foundation
引用
收藏
页码:89 / 95
页数:7
相关论文
共 85 条
[1]   Nitric oxide synthases: structure, function and inhibition [J].
Alderton, WK ;
Cooper, CE ;
Knowles, RG .
BIOCHEMICAL JOURNAL, 2001, 357 (03) :593-615
[2]   L-arginine-nitric oxide kinetics in nonnal and type 2 diabetic subjects -: A stable-labelled 15N arginine approach [J].
Avogaro, A ;
Toffolo, G ;
Kiwanuka, E ;
de Kreutzenberg, SV ;
Tessari, P ;
Cobelli, C .
DIABETES, 2003, 52 (03) :795-802
[3]   Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention [J].
Balestrieri, Maria Luisa ;
Lu, Shi-Jiang ;
de Nigris, Filomena ;
Giovane, Alfonso ;
Williams-Ignarro, Sharon ;
D'Armiento, Francesco Paolo ;
Feng, Qiang ;
Fiorito, Carmela ;
Testa, Gianluca ;
Pastore, Lucio ;
Cacciatore, Francesco ;
Mancini, Francesco Paolo ;
Servillo, Luigi ;
De Rosa, Gaetano ;
Pagliarulo, Caterina ;
Rienzo, Monica ;
Minucci, Pellegrino Biagio ;
Farzati, Bartolomeo ;
Salvatore, Francesco ;
Rengo, Franco ;
Ignarro, Louis Joseph ;
Giordano, Antonio ;
Baker, Andrew ;
Lanza, Robert ;
Napoli, Claudio .
ATHEROSCLEROSIS, 2010, 209 (02) :403-414
[4]   S-Nitrosoglutathione and Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Regulate Compartmentalized Ras S-Nitrosylation and Stimulate Cell Proliferation [J].
Batista, Wagner L. ;
Ogata, Fernando T. ;
Curcio, Marli F. ;
Miguel, Rodrigo B. ;
Arai, Roberto J. ;
Matsuo, Alisson L. ;
Moraes, Miriam S. ;
Stern, Arnold ;
Monteiro, Hugo P. .
ANTIOXIDANTS & REDOX SIGNALING, 2013, 18 (03) :221-238
[5]   Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme [J].
Bauer, PM ;
Buga, GM ;
Fukuto, JM ;
Pegg, AE ;
Ignarro, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) :34458-34464
[6]   Nitric oxide (NO) - Biogeneration, regulation, and relevence to human diseases [J].
Bian, K ;
Murad, F .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 :D264-D278
[7]   Proteomic modification by nitric oxide [J].
Bian, Ka ;
Ke, Yan ;
Kamisaki, Yoshinori ;
Murad, Ferid .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 (04) :271-279
[8]   Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release [J].
Borutaite, Vilmante ;
Morkuniene, Ramune ;
Arandarcikaite, Odeta ;
Jekabsone, Aiste ;
Barauskaite, Jurgita ;
Brown, Guy C. .
JOURNAL OF BIOMEDICAL SCIENCE, 2009, 16
[9]   Nitrosyl-cobinamide, a new and direct nitric oxide-releasing drug effective in vivo [J].
Broderick, Kate E. ;
Alvarez, Luis ;
Balasubramanian, Mahesh ;
Belke, Darrell D. ;
Makino, Ayako ;
Chan, Adriano ;
Woods, Virgil L., Jr. ;
Dillmann, Wolfgang H. ;
Sharma, Vijay S. ;
Pilz, Renate B. ;
Bigby, Timothy D. ;
Boss, Gerry R. .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 232 (11) :1432-1440
[10]   Sustained release nitric oxide from long-lived circulating nanoparticles [J].
Cabrales, Pedro ;
Han, George ;
Roche, Camille ;
Nacharaju, Parimala ;
Friedman, Adam J. ;
Friedman, Joel M. .
FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 (04) :530-538